Cardiac magnetic resonance spectroscopy: Potential clinical applications

Herz

Volumn 25, Issue 4, 2000, Pages 452-460

  Neubauer, Stefan ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

ATP; Coronary artery disease; Heart failure; MR spectroscopy; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; POTASSIUM; RUBIDIUM; SODIUM 23;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CORONARY ARTERY DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE METABOLISM; HEART TRANSPLANTATION; HEART VALVE REPLACEMENT; HIGH ENERGY PHOSPHATE; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; VALVULAR HEART DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CORONARY DISEASE; CRICETINAE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MESOCRICETUS; MYOCARDIUM; RATS; TURKEYS;

EID: 0033925579     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000590050037     Document Type: Article

References (45)

1. Auffermann W, Chew WM, Wolfe CL, et al. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging. Radiology 1991;179:253-9.
2. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem 1985;260:3512-7
3. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation 1987;75: 196-101
4. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998;351:714-8.
5. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology 1994;191:593-612.
6. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med 1996;35:664-70.
7. 31P NMR. J Magn Reson 1992;99:443-8.
8. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med 1990;14:425-34.
9. Bottomley PA, Weiss RG, Hardy CJ, et al. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology 1991;181:67-75.
10. Clarke K, O'Connor AJ, Willis RJ. Temporal relation between energy metabolism and myocardial function during ischemia and reperfusion. Am J Physiol 1987;253.H412-21.
11. Clarke K, Stewart LC, Neubauer S, et al. Extracellular volume and transsarcolemmal proton movement during ischemia and reperfusion: a 31P NMR spectroscopic study of the isovolumic rat heart. NMR Biomed 1993;6:278-86.
12. Conway MA, Allis J, Ouwerkerk R, et al. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991;338:973-6.
13. de Roos A, Doornbos J, Luyten PR, et al. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 1992;2:711-9.
14. DeLayre JL, Ingwall JS, Malloy C, et al. Gated sodium-23 nuclear magnetic resonance images of an isolated perfused working rat heart. Science 1981;212:935-6.
15. Flameng W, Vanhaecke J, van Belle H, et al. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans. J Am Coll Cardiol 1987;9:1235-42.
16. Forsen S, Hofman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963;39:2892-901.
17. Fraser CD Jr, Chacko VP, Jacobus WE, et al. Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant 1990;9:197-204.
18. Hardy CJ, Weiss RG, Bottomley PA, et al. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
19. Ingwall JS. How high does intracellular sodium rise during acute myocardial ischaemia? A view from NMR spectroscopy. Cardiovasc Res 1995;29:2.
20. Jung WI, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-42.
21. Kim RJ, Lima JAC, Chen EL, et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997;95:1877-85.
22. Kreutzer U, Jue T. 1H-nuclear magnetic resonance deoxymyoglobin signal as indicator of intracellular oxygenation in myocardium. Am J Physiol 1991;261:H2091-7.
23. Liao R, Nascimben L, Friedrich J, et al. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893-902.
24. Menon RS, Hendrich K. 31P NMR spectroscopy of human heart at 4T: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium. Magn Reson Med 1992;26:368-76.
25. Nascimben L, Friedrich J, Liao R, et al. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995;91:1824-33.
26. 31P-NMR magnetization transfer study of the isolated ferret heart. Circ Res 1988;63:1-15.
27. Neubauer S, Horn M, Cramer M, et al. In patients with dilated cardiomyopathy the myocardial phosphocreatine-to-ATP ratio is a predictor of mortality. Circulation 1997;96:2190-6.
28. Neubauer S, Horn M, Naumann A, et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 1995;95:1092-100.
29. 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J 1995;16:Suppl O:115-8.
30. Neubauer S, Horn M, Pabst T, et al. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Invest Med 1997;45: 453-62.
31. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-8.
32. Pluim BM, Chin JC, De Roos A, et al. Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy [see comments]. Eur Heart J 1996;17: 1271-8.
33. 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique. Ann NY Acad Sci 1987;508: 321-32.
34. Schaefer S, Gober JR, Schwartz GG, et al. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 1990;65:1154-61.
35. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
36. Springer CS Jr, Pike MM, Balschi JA, et al. Use of shift reagents for nuclear magnetic resonance studies of the kinetics of ion transfer in cells and perfused hearts. Circulation 1985;72:89-93.
37. Ugurbil K, Petein M, Madian R, et al. High resolution proton NMR studies of perfused rat hearts. FEBS letters 1984;167:73-8.
38. van Dobbenburgh JO, Klopping C, Lahpor JR, et al. Altered myocardial energy metabolism in heart transplant patients: consequence of rejection or a postischemic phenomenon? Proc Soc Magn Reson Med 1993:1093.abstract.
39. von Kienlin M, Mejia R. Spectral localization with optimal point-spread function. Magn Reson Med 1991;94:268-87.
40. 31P magnetic resonance spectroscopic imaging of regional high-energy phosphate metabolism in injured rat heart. Magn Reson Med 1998;39:731-41
41. Wallimann T, Wyss M, Brdiczka D, et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The "phosphocreatine circuit" for cellular energy homeostasis. Biophys J 1992;281:21-40.
42. Weiss RG, Bottomley PA, Hardy CJ, et al. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease [see comments]. N Engl J Med 1990;323:1593-600.
43. 31P magnetic resonance spectroscopy [see comments]. Circulation 1995;92:15-23.
44. Zhang J, Merkle H, Hendrich K, et al. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 1993;92:993-1003.
45. 31P-MRS study. Circulation 1996;94: 1089-100.